Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market, Size, Share, Growth, Trends, Insight and Industry Forecast, 2021-2028

SKU: DMAG2108 | Last Updated On: Apr 16 2021 | No. of Pages: 180 | Available Formats

> Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Expected to reach at a high CAGR by 2027: DataM Intelligence

Global veno-venous Extracorporeal Life Support (VV ECLS) Devices Market is segmented By Product Type (Single-ventricular device, Biventricular device), By Application (Femoral vein, Jugular vein, Right atrium, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market is expected to grow at a high CAGR during the forecasting period (2020-2027).

Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique that provides prolonged cardiac and respiratory support to the heart and lungs are which are not able to provide an adequate amount of gas exchange or perfusion to sustain life. The technology for ECLS is derived from cardiopulmonary bypass, which provides shorter-term support with arrested native circulation.

In venovenous (VV) ECLS, cannulae are placed in the right common femoral vein for drainage and right internal jugular vein for infusion. Alternatively, a dual-lumen catheter is inserted into the right internal jugular vein, draining blood from the superior and inferior vena cavae and returning it to the right atrium.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

The global venovenous extracorporeal life support (VV ECLS) devices market is growing due to several driving factors such as increasing the prevalence of cardiopulmonary disease & respiratory disorders and rising awareness towards cardiopulmonary disease and increasing demand for cardiopulmonary monitoring and treatment system.

According to the World Heal and Organization (WHO), 17.5 million people died due to cardiopulmonary disease, representing more than 30% of the global death in 2015. Cardiopulmonary diseases are rising due to several factors such as the growing geriatric population, rising disposable income, changing lifestyle, smoking, and others. The Venovenous extracorporeal life support (VV ECLS) devices help the patients maintain the body to a normal level through appropriate intervention. These devices have shown favorable neonatal results and help maintain acute respiratory distress syndrome (ARDS) and single-ventricle physiology. As of January 2016, 73,596 patients had been placed on extracorporeal life support (ECLS) internationally, of which 36,246 were neonates, and 18,019 were older children. The number of registered ELSO centers and their yearly use of ECLS have increased precipitously in the last few years to 298 centers and 6,177 cases/year, respectively.

However, several complications associated with extracorporeal life support devices, such as bleeding, infections, and technical failures, coupled with a high cost of the devices and lack of skilled professionals, hinder the market's growth.

Market Segmentation

The venovenous extracorporeal life support (VV ECLS) devices market is a segment, hindergle-ventricular device, and biventricular device by product type. Among these, the venovenous extracorporeal life support (VV ECLS) devices in single-ventricle patients have increased the market share in 2018 and are estimated to grow significantly over the forecast period. Single site dual-lumen cannulas are used in infants, children, and adults. This approach incorporates both drainage and reinfusion lumens into one unit inserted through the right internal jugular vein (RIJV). However, the venovenous ECLS has a substantial risk in patients with single-ventricle disorder due to the coronary, pulmonary, and cerebral circulations' vulnerability. Biventricular devices support with a paracorporeal pulsatile device is known to be an efficient bridge to recovery for patients with fulminant myocarditis-related cardiogenic shock.

Based on application, the venovenous extracorporeal life support (VV ECLS) devices market is segmented into the right atrium, jugular vein, femoral vein, and others. The venovenous extracorporeal life support (VV ECLS) devices effectively result in the jugular vein and right atrium. Femoro-Jugular VV ECMO requires the insertion of two cannulas; one is for blood drainage from the venous system [superior vena cava (SVC)] to the ECMO circuit, the second returns the oxygenated blood to the right atrium (RA) or left internal jugular vein (LIJV. This is a key factor for the variability as multiple site access can be approached [right internal jugular vein (RIJV) being always the first option].

Source: DataM Intelligence Analysis (2019)

Geographical Analysis

North America is dominating the global veno-venous extracorporeal life support (VV ECLS) devices market, accounting for the largest market share in 2018, owing to the rising prevalence of cardiopulmonary diseases, growing aging population and active intervention by the government like the “Million Hearts” initiative by US government to spread awareness about risk associated with cardiopulmonary diseases. According to the American Heart Association, cardiovascular disease remains the leading cause of death in the United States, responsible for 840,768 deaths (635,260 cardiac) in 2016. From 2006 to 2016, the US death rate from CVD decreased by 18.6% and from coronary heart disease by 31.8%. The North American VV ECLS market is expected to grow rapidly over the forecast period, owing to the rising demand for new innovative products. Terumo Cardiovascular Systems Corporation has made refinements in existing technology while manufacturing CAPIOX FX Oxygenator.

According to the Japan Aging Research Center, the Asia–Pacific is on the verge of suffering from aging. Japan, China, and South Korea are the countries experiencing the most serious aging population problem, followed by rising risk for the cardiopulmonary growing prevalence of cardiovascular and cardiopulmonary diseases in Asia will be responsible for an increase in cardiopulmonary diseases burden across the region. The region also constitutes some of the developed markets, such as Austraincrease, to the UNFPA. By 2050, one in four people in Asia and the Pacific will be over 60 years old. The population of older persons (aged over 60) will triple between 2010 and 2050, reaching close to 1.3 billion people. Also, high awareness and huge demand for venovenous extracorporeal life support (VV ECLS) devices drive the market's growth in this region.

Source: DataM Intelligence Analysis (2019)

Competitive Landscape

The veno-venous extracorporeal life support (VV ECLS) devices market is competitive with few major players. Some of the major players in the global veno-venous extracorporeal life support (VV ECLS) devices market include Medtronic, Plc, MAQUET Holding B. V. & Co. KG (Getinge Group), Microport Scientific Corporation, Sorin Group, Nipro Medical Corporation, Terumo Cardiovascular Systems Corporation, MedosMedizintechnik AG, among others.

The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations contributing to the veno-venous extracorporeal life support (VV ECLS) devices market globally. For instance,

In July 2019, Hemovent GmbH received CE Marking for its MOBYBOX ECLS System, allowing it to market its product throughout the European Union. MOBYBOX is the world’s first self-contained and fully integrated Extracorporeal Life Support (ECLS) system, designed with an ultimate focus on safety, ease of use, mobility, and high performance to support or replace heart and lung function in the event of cardiac and/or respiratory failure.

In July 2019, UK-based medical technology firm LivaNova introduced the CE-Marked Bi-Flow arterial femoral cannula to prevent leg ischemia during cardiac surgery.

In June 2019, Orchestra BioMed Inc. formed a global strategic partnership with Terumo Corporation to develop and commercialize the Virtue Sirolimus-Eluting Balloon (SEB).

Why Purchase the Report?

  • Visualize the composition of the veno-venousto develop and commercialize market segmentation by product type, application, and end-user, highlighting the key commercial assets and players.

  • Identify commercial opportunities in the veno-venous extracorporeal life support (VV ECLS) devices market by analyzing trends and co-development deals.

  • Excel data sheet with thousands of data points of veno-venous extracorporeal life support (VV ECLS) devices market-level 4/5 segmentation.

  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • Product mapping in excel for the key product of all major market players

The Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market report would provide access to an approx. 45 market data table, 43 figures and 195 pages.

 

Target Audience

  • Service Providers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers

Related Topic's

Arrhythmogenic Right Ventricular Dysplasia Market

Left Ventricular Assist Device (LVAD) Market

      

 

Table of Contents

  1. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Methodology and Scope
    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – Market Definition and Overview
  3. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – Executive Summary
    1. Market Snippet by Product Type
    2. Market Snippet by Application
    3. Market Snippet by End-User
    4. Market Snippet by Region
  4. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – Market Dynamics
    1. Market Impacting Factors
      1. Drivers
        1. Growing geriatric population
        2. Rising disposable income
      2. Restraints
        1. High cost of the devices
      3. Opportunity
      4. Impact Analysis
  5. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – Industry Analysis
    1. Porter's Five Forces Analysis
    2. Regulatory Analysis
    3. Reimbursement Scenario
    4. Supply Chain Analysis
    5. Pricing Analysis
    6. Product Innovations
    7. Unmet Needs
  6. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – By Product Type
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    3. Market Attractiveness Index, By Product Type Segment
      1. Single-ventricular device*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Biventricular device
  7. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – By Application
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    3. Market Attractiveness Index, By Application Segment
      1. Femoral vein*
        1. Introduction
        2.  Market Size Analysis and Y-o-Y Growth Analysis (%)
      2. Jugular vein
      3. Right atrium
      4. Others
  8. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – By End-User
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    3. Market Attractiveness Index, By End-User Segment
      1. Hospitals*
        1. Introduction
        2.  Market Size Analysis and Y-o-Y Growth Analysis (%)
      2. Clinics
      3. Ambulatory Surgical Centers (ASCs)
      4. Others
  9. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – By Region
    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4.  Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4.  Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4.  Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4.  Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4.  Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  10. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – Competitive Landscape
    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market- Company Profiles
    1. Medtronic, Plc.*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. MAQUET Holding B. V. & Co. KG
    3. Microport Scientific Corporation
    4. Sorin Group
    5. Nipro Medical Corporation
    6. Terumo Cardiovascular Systems Corporation
    7. MedosMedizintechnik AG

LIST NOT EXHAUSTIVE

  1. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – Premium Insights
  2. Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market – DataM
    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

List of Tables

Table 1  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2018,2022 & 2027 ($ Million)

Table 2  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2018,2022 & 2027 ($ Million)

Table 3  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2018,2022 & 2027 ($ Million)

Table 4  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2018,2022 & 2027 ($ Million)

Table 5  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 6  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2018,2022 & 2027 ($ Million)

Table 7  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2017-2027 ($ Million)

Table 8  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2018,2022 & 2027 ($ Million)

Table 9  Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2017-2027 ($ Million)

Table 10 North America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 11 North America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2017-2027 ($ Million)

Table 12 North America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2017-2027 ($ Million)

Table 13 South America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 14 South America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2017-2027 ($ Million)

Table 15 South America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2017-2027 ($ Million)

Table 16 Europe Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 17 Europe Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2017-2027 ($ Million)

Table 18 Europe Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2017-2027 ($ Million)

Table 19 Asia-Pacific Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 20 Asia-Pacific Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2017-2027 ($ Million)

Table 21 Asia-Pacific Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2017-2027 ($ Million)

Table 22 Middle East & Africa Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Product Type, 2017-2027 ($ Million)

Table 23 Middle East & Africa Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By Application, 2017-2027 ($ Million)

Table 24 Middle East & Africa Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, By End-User, 2017-2027 ($ Million)

Table 25 Medtronic, Plc.: Overview

Table 26 Medtronic, Plc.: Product Portfolio

Table 27 Medtronic, Plc.: Key Developments

Table 28 MAQUET Holding B. V. & Co. KG: Overview

Table 29 MAQUET Holding B. V. & Co. KG: Product Portfolio

Table 30 MAQUET Holding B. V. & Co. KG: Key Developments

Table 31 Microport Scientific Corporation: Overview

Table 32 Microport Scientific Corporation: Product Portfolio

Table 33 Microport Scientific Corporation: Key Developments

Table 34 Sorin Group: Overview

Table 35 Sorin Group: Product Portfolio

Table 36 Sorin Group: Key Developments

Table 37 Nipro Medical Corporation: Overview

Table 38 Nipro Medical Corporation: Product Portfolio

Table 39 Nipro Medical Corporation: Key Developments

Table 40 Terumo Cardiovascular Systems Corporation: Overview

Table 41 Terumo Cardiovascular Systems Corporation: Product Portfolio

Table 42 Terumo Cardiovascular Systems Corporation: Key Developments

Table 43 MedosMedizintechnik AG: Overview

Table 44 MedosMedizintechnik AG: Product Portfolio

Table 45 MedosMedizintechnik AG: Key Developments

 

List of Figures

Figure 1 Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 2 Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Application, 2018 & 2027 (%)

Figure 3 Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By End-User, 2018 & 2027 (%)

Figure 4 Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 5 Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Y-o-Y Growth, By Product Type, 2018-2027 (%)

Figure 6 Single-ventricular device: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 7 Biventricular device: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 8 Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Y-o-Y Growth, By Application, 2018-2027 (%)

Figure 9 Jugular vein: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 10           Right atrium: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 11           Femoral vein: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 12           Others: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 13           Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Y-o-Y Growth, By End-User, 2018-2027 (%)

Figure 14           Hospitals & Clinics: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 15           Ambulatory Surgical Centers (ASCs): Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 16           Others: Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 17           North America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 18           North America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 19           North America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Application, 2018 & 2027 (%)

Figure 20           North America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By End-User, 2018 & 2027 (%)

Figure 21           South America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 22           South America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 23           South America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Application, 2018 & 2027 (%)

Figure 24           South America Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By End-User, 2018 & 2027 (%)

Figure 25           Europe Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 26           Europe Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 27           Europe Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Application, 2018 & 2027 (%)

Figure 28           Europe Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By End-User, 2018 & 2027 (%)

Figure 29           Asia-Pacific Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 30           Asia-Pacific Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 31           Asia-Pacific Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Application, 2018 & 2027 (%)

Figure 32           Asia-Pacific Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By End-User, 2018 & 2027 (%)

Figure 33           Middle East & Africa Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Value, 2017-2027 ($ Million)

Figure 34           Middle East & Africa Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Product Type, 2018 & 2027 (%)

Figure 35           Middle East & Africa Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By Application, 2018 & 2027 (%)

Figure 36           Middle East & Africa Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Share, By End-User, 2018 & 2027 (%)

Figure 37           Medtronic, Plc.: Financials

Figure 38           MAQUET Holding B. V. & Co. KG: Financials

Figure 39           Microport Scientific Corporation: Financials

Figure 40           Sorin Group: Financials

Figure 41           Nipro Medical Corporation: Financials

Figure 42           Terumo Cardiovascular Systems Corporation: Financials

Figure 43           MedosMedizintechnik AG: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest